FDA clears XACT ACE Xtend remote control unit
The U.S. Food and Drug Administration cleared the ACE Xtend remote control unit for the XACT ACE robotic system.
Evidence notes
- The clearance permits robotic instrument insertion and steering from an interventional-radiology control room.
- ACE Xtend is designed to reduce staff radiation exposure and physical strain while improving workflow.
- The remote-control unit operates with the FDA-cleared XACT ACE system for CT-guided percutaneous procedures.
Company context
XACT Robotics develops hands-free robotic guidance and needle-insertion systems for image-guided percutaneous procedures. Its platform is designed to improve targeting accuracy and consistency during biopsies and ablations and has received both FDA clearance and European approval.